CL2013001330A1 - Virus aislado con arn de cadena positiva y que carece de envoltura; secuencia de acido nucleico que codifica dicho virus; vector, celula ; anticuerpo; composición inmunogénica que comprende dicho virus; metodo de detección de un virus. - Google Patents
Virus aislado con arn de cadena positiva y que carece de envoltura; secuencia de acido nucleico que codifica dicho virus; vector, celula ; anticuerpo; composición inmunogénica que comprende dicho virus; metodo de detección de un virus.Info
- Publication number
- CL2013001330A1 CL2013001330A1 CL2013001330A CL2013001330A CL2013001330A1 CL 2013001330 A1 CL2013001330 A1 CL 2013001330A1 CL 2013001330 A CL2013001330 A CL 2013001330A CL 2013001330 A CL2013001330 A CL 2013001330A CL 2013001330 A1 CL2013001330 A1 CL 2013001330A1
- Authority
- CL
- Chile
- Prior art keywords
- virus
- lacking
- sheath
- antibody
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20101604 | 2010-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013001330A1 true CL2013001330A1 (es) | 2014-05-23 |
Family
ID=46083543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013001330A CL2013001330A1 (es) | 2010-11-15 | 2013-05-14 | Virus aislado con arn de cadena positiva y que carece de envoltura; secuencia de acido nucleico que codifica dicho virus; vector, celula ; anticuerpo; composición inmunogénica que comprende dicho virus; metodo de detección de un virus. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2640832B1 (es) |
CA (1) | CA2817933A1 (es) |
CL (1) | CL2013001330A1 (es) |
NO (1) | NO2640832T3 (es) |
WO (1) | WO2012066481A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO344698B1 (en) * | 2018-06-15 | 2020-03-09 | Patogen As | Novel fish virus |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
CA2570050C (en) | 2004-06-11 | 2013-03-05 | Pharmaq As | Heart and skeletal muscle inflammation (hsmi) virus |
CA2634144C (en) * | 2007-06-28 | 2018-01-02 | Pharmaq As | Novel fish pathogen |
-
2011
- 2011-11-15 WO PCT/IB2011/055103 patent/WO2012066481A1/en active Application Filing
- 2011-11-15 NO NO11841118A patent/NO2640832T3/no unknown
- 2011-11-15 EP EP11841118.0A patent/EP2640832B1/en active Active
- 2011-11-15 CA CA2817933A patent/CA2817933A1/en active Pending
-
2013
- 2013-05-14 CL CL2013001330A patent/CL2013001330A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2640832A4 (en) | 2014-11-12 |
WO2012066481A1 (en) | 2012-05-24 |
CA2817933A1 (en) | 2012-05-24 |
EP2640832A1 (en) | 2013-09-25 |
NO2640832T3 (es) | 2018-05-19 |
EP2640832B1 (en) | 2017-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012024287A2 (pt) | anticorpo, composição farmacêutica, método, ácido nucleico, vetor de expressão e célula hospedeira | |
WO2013006756A3 (en) | Alpha amylase variants and polynucleotides encoding same | |
CL2014003131A1 (es) | Una proteína de unida al antígeno st2; acido nucleico que la codifica; y sus usos. | |
WO2013057141A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
WO2014177546A3 (en) | Glucoamylase variants and polynucleotides encoding same | |
HK1215954A1 (zh) | 蛋白、核酸、和抗體及其用途 | |
WO2013057143A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
MX351762B (es) | Variantes de glucoamilasas y polinucleotidos que las codifican. | |
BR112013020070A2 (pt) | moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas | |
WO2012044915A3 (en) | Beta-glucosidase variants and polynucleotides encoding same | |
BR112012022046A2 (pt) | ''anticorpo,composição farmacêutica,ácido nucleico ,vetores de expressão,célula hospedeira e método para a produção de um anticorpo recombinante''. | |
BR112013018311A2 (pt) | sequência de ácido nucleico isolada, receptor de antígeno quimérico isolado, célula t geneticamente modificada, vetor, e, uso de uma célula t geneticamente modificada. | |
WO2013006544A8 (en) | Methods for making multimeric polypeptides | |
MX2014002415A (es) | Variantes de glucoamilasas y polinucleotidos que las codifican. | |
BR112013033350A2 (pt) | imunocitocina, ácido nucleico, vetor, célula hospedeira e composição farmacêutica | |
WO2010127304A3 (en) | Sequencing methods | |
WO2011142970A3 (en) | Her2 nucleic acid aptamers | |
WO2013119302A3 (en) | Gh61 polypeptide variants and polynucleotides encoding same | |
EP3696265A3 (en) | Lipase variants and polynucleotides encoding same | |
ZA201306009B (en) | Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same | |
WO2011109524A3 (en) | Xylanase variants and polynucleotides encoding same | |
WO2013096603A3 (en) | Cellobiohydrolase variants and polynucleotides encoding same | |
WO2014195356A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
AR079704A1 (es) | Anticuerpos anti-bv8 y sus usos | |
EP2539354A4 (en) | FOR RANTES-CODING NUCLEIC ACID MOLECULES AND COMPOSITIONS AND METHODS THEREWITH |